fbpx
Home > Blog > Nutraceuticals and the Genomic Revolution [White Paper]

Nutraceuticals and the Genomic Revolution [White Paper]

When the human genome was sequenced in the early 2000s, it promised to change the field of biomedical research by providing better insight into the human body and how drugs and other substances affect us. Perhaps surprisingly, the genomic revolution has also greatly impacted the nutraceutical industry – scientific data began entering public consciousness and consequently, consumer interest in nutraceutical products have skyrocketed, but these customers have also begun demanding more research to back-up product claims.

In recent years, the nutraceutical industry has seen rapid growth and change as consumers have become more interested in nutraceutical products, but also demanding more research to back-up product claims. This in turn has led the nutraceutical industry to adopt a new science based paradigm.

In this white paper, we discuss how you can leverage scientific studies to:

  • Increase your customer confidence
  • Attract new investments,
  • Develop new products
  • Protect your intellectual property (IP)
  • More…

About The Author

InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.

Share this articles

Facebook
Twitter
Pinterest
LinkedIn
InVivo Biosystems

About the Author:

Connect with us